Mechanistic Approaches to Inhibition of Emerging DNA Viruses
抑制新兴 DNA 病毒的机制方法
基本信息
- 批准号:9456556
- 负责人:
- 金额:$ 25.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-01 至 2020-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAlabamaAmino AcidsAnabolismAntibodiesAntiviral AgentsBiological AssayBiological AvailabilityBiologyBromodeoxyuridineCaliforniaCell Culture TechniquesCellsCidofovirClinicClinicalCollaborationsCytomegalovirusCytoplasmDNADNA VirusesDataDetectionDevelopmentDiseaseEffectivenessEstersEvaluationExhibitsFamilyFibroblastsFoscarnetFutureGoalsHHV-6BHealthHerpesviridaeHerpesvirus 1HumanIn VitroIndividualInfectionIntestinesLaboratoriesLengthLiquid substanceLiverMeasuresMetabolicMetabolismMethodsMolecularMolecular ProbesMolecular StructureNucleosidesNucleotidesOralOrthopoxvirusParentsPathogenicityPermeabilityPharmaceutical ChemistryPharmaceutical PreparationsPharmacologyPhosphate BufferPhospholipase CPhospholipidsPhysiologicalPlasmaPolyomavirusPositioning AttributeProdrugsPropertyPublic HealthRattusResearchResearch PersonnelResearch Project GrantsSeriesSolubilityStomachStructureStructure-Activity RelationshipTissuesTranslationsUnited States National Institutes of HealthUniversitiesVaccinia virusVariantViralVirusVirus Diseasesadenine analogalkyl groupanaloganti-viral efficacyaqueouscytotoxicitydesigneffective therapyefficacy testinggastricsinimprovedin vitro activityindexinginnovationinsightlipophilicitynephrotoxicitynovelnovel therapeuticspathogenpenis foreskinphosphonateprofessorscaffoldtooluptakeviral DNA
项目摘要
PROJECT SUMMARY
The NIH has identified a group of infective viruses as “emerging” because they are a growing threat to public
health. This high priority list includes several DNA viruses. Infections with DNA viruses result in significant
disease, but few drugs have been approved for this class of pathogens. Cidofovir (CDV, HPMPC) is an acyclic
nucleoside phosphonate (ANP) known to exhibit activity against a spectrum of DNA viruses. However, like other
ANPs as a class, CDV has significant drawbacks, including inherent lack of oral bioavailability, relatively low
potency and nephrotoxicity. Certain novel N-alkyl tyrosinamide prodrugs of CDV and its adenine analog HPMPA
recently designed and synthesized by the PI, Professor Charles McKenna at the University of Southern California
(USC) exhibit greatly enhanced in vitro potency against CMV and several other DNA viruses relative to the parent
drugs and improved selectivity indices. An important virus-dependent variation in potency, selectivity and efficacy
enhancement is observed, which has not been explained mechanistically. In this R21 project, these prodrugs
and a series of analogs with modified promoiety structures designed to affect activation by phospholipase C will
be evaluated for stability and permeability under physiological conditions and for activity against CMV, HSV1,
VACV and two emerging DNA viruses: HHV-6B and BK virus. The research will focus on associating individual
promoiety structural features with uptake into infected cells and release of drug into the cytoplasm for uptake
into viral DNA for each virus, using novel 5-BrHPMPU prodrug derivatives as probes. This information, correlated
with the stability, metabolism and in vitro antiviral efficacy data for the five viruses will provide important insights
into the mechanism underlying the exceptional but varied potency of this new class of prodrugs with respect to
the viruses investigated, while introducing an innovative molecular tool to determine drug promoiety
effectiveness. It is also expected to identify new, highly potent compounds for future development into effective
therapies for infections by these viruses.
项目摘要
美国国立卫生研究院已经确定了一组传染性病毒为“新兴”,因为它们对公众的威胁越来越大。
健康这个高优先级列表包括几种DNA病毒。DNA病毒感染会导致
疾病,但很少有药物已被批准用于这类病原体。西多福韦(Cidofovir,CDV,HPMPC)是一种无环
已知核苷膦酸酯(ANP)对一系列DNA病毒表现出活性。然而,像其他
作为一类ANP,CDV具有显著的缺点,包括固有地缺乏口服生物利用度,相对低,
效力和肾毒性。CDV的N-烷基酪氨酸酰胺前药及其腺嘌呤类似物HPMPA
最近由PI设计和合成,南加州大学的查尔斯·麦肯纳教授
(USC)与亲本相比,对CMV和几种其它DNA病毒的体外效力大大增强
药物和改进的选择性指数。效价、选择性和有效性的重要病毒依赖性变化
观察到增强,这还没有被机械地解释。在这个R21项目中,这些前药
一系列具有修饰的前体结构的类似物被设计成影响磷脂酶C的活化,
评价在生理条件下的稳定性和渗透性以及抗CMV,HSV 1,
VACV和两种新出现的DNA病毒:HHV-6 B和BK病毒。研究将集中在将个人
前体结构特征与被感染细胞的摄取和药物释放到细胞质中用于摄取
每种病毒的病毒DNA,使用新的5-BrHMPU前药衍生物作为探针。这些信息,相关
这五种病毒的稳定性、代谢和体外抗病毒效力数据将提供重要的见解
这类新的前药在以下方面的特殊但不同的效力的潜在机制
研究的病毒,同时引入了一种创新的分子工具来确定药物前体
有效性它还有望确定新的,高效的化合物,用于未来开发有效的
治疗这些病毒感染的方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLES E MCKENNA其他文献
CHARLES E MCKENNA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLES E MCKENNA', 18)}}的其他基金
Selective inhibition of fungal BET protein Bdf1
选择性抑制真菌 BET 蛋白 Bdf1
- 批准号:
9228913 - 财政年份:2016
- 资助金额:
$ 25.55万 - 项目类别:
Selective inhibition of fungal BET protein Bdf1
选择性抑制真菌 BET 蛋白 Bdf1
- 批准号:
9112762 - 财政年份:2016
- 资助金额:
$ 25.55万 - 项目类别:
Molecular and cellular mechanism of ONJ related to osteoclast inhibition
ONJ抑制破骨细胞相关的分子细胞机制
- 批准号:
8638613 - 财政年份:2014
- 资助金额:
$ 25.55万 - 项目类别:
Molecular and cellular mechanism of ONJ related to osteoclast inhibition
ONJ抑制破骨细胞相关的分子细胞机制
- 批准号:
8883486 - 财政年份:2014
- 资助金额:
$ 25.55万 - 项目类别:
Chemical Synthesis, Biochemistry & Spectroscopic Analysis
化学合成、生物化学
- 批准号:
8591732 - 财政年份:2013
- 资助金额:
$ 25.55万 - 项目类别:
BIOLOGICALLY ACTIVE FLUOROPHOSPHONATE DERIVATIVES
生物活性氟代磷酸盐衍生物
- 批准号:
3132316 - 财政年份:1985
- 资助金额:
$ 25.55万 - 项目类别:
BIOLOGICALLY ACTIVE FLUOROPHOSPHONATE DERIVATIVES
生物活性氟代磷酸盐衍生物
- 批准号:
3132319 - 财政年份:1985
- 资助金额:
$ 25.55万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 25.55万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 25.55万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 25.55万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 25.55万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 25.55万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 25.55万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 25.55万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 25.55万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 25.55万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 25.55万 - 项目类别:
Grant-in-Aid for Early-Career Scientists